US Patent Issued to Basilea Pharmaceutica International, Allschwil on Jan. 13 for "Use of compounds in the treatment of fungal infections" (California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,406, issued on Jan. 13, was assigned to Basilea Pharmaceutica International AG, Allschwil (Allschwil, Switzerland).

"Use of compounds in the treatment of fungal infections" was invented by Karen Joy Shaw (Poway, Calif.) and Michael Hodges (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is the use of compound 1, an antifungal agent with a novel mechanism of action, in the treatment of fungal infections."

The patent was filed on March 2, 2021, under Application No. 17/908,079.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u...